CEACAM5 and neoplasm: Carcinoembryonic antigen (CEA) has been the only biomarker recommended by the American Society of Clinical Oncology and the European Group on Tumor Markers for use in the postoperative period for the early detection of recurrent or metastatic CRC 8.